Abstract
Neopterin is compared with other tumor markers in colorectal carcinoma. Its sensitivity is clearly lower than that of CEA, TPA and CA 19/9 and is even lower than the sensivity of the erythrocyte sedimentation rate. The ability of neopterin to discriminate between different tumor stages is also lower than that of the other markers. The discriminant analysis shows that measurement of neopterin in the serum of patients with colorectal carcinoma gives no essential additional information.
Similar content being viewed by others
References
Boey J, Cheung HC, Lai CK, Wong J. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J Surg 1984;8:279–86.
Heptner G, Domschke S, Krapf F, Schneider MU, Iro H, Domschke W. Vergleich der Tumormarker CEA und CA 19/9 in der kolorektalen Diagnostik. Dtsch Med Wochenschr 1984;109:1309–12.
Lunde OC, Havig O. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Acta Chir Scand 1982;148:189–93.
Mross KB, Wolfrum DI, Rauschecker H. Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controls. Oncology 1985;42:288–95.
Putzki H, Student A, Jablonski M, Heymann H. Comparison of the tumor markers CEA, TPA and CA19/9 in colorectal carcinoma. Cancer 1987;59:223–6.
Quentmeier A, Schlag P, Herfarth C. Schlüsselrolle des CEA-Testes für die Diagnostik des rezidivierten colorectalen Carcinoms. Chirurg 1986;57:83–7.
Wedell J, Meier zu Eissen P, Luu TH, et al. A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer. Dis Colon Rectum 1981;24:618–21.
Staab HJ, Brümmendorf T, Hornung A, Kieninger G. The clinical validity of circulating tumor-associated antigens primary diagnosis and follow-up of patients with gastrointestinal malignancies. Klin Wochenschr 1985;63:106–15.
Wachter H, Hausen A, Grassmary K. Erhöhte Ausscheidung von Neopterin im Harn von Patienten mit malignen Tumoren und mit Viruserkrankungen. Z Physiol Chem 1979;360:1957–60.
Bichler A, Fuchs D, Hausen A, Hetzel H, König K, Wachter H. Urinary neopterine excretion in patients with genital cancer. Clin Biochem 1982;15:38–40.
Stea B, Halpern RM, Halpern BC, Smith RA. Urinary excretion levels of unconjugated pterins in cancer patients and normal individuals. Clin Chim Acta 1981;113:231–42.
Rokos K, Rokos H, Frisius H. Pteridines as tumor markers? Attempt of evaluation by HPLC and a radioimmunoassay for neopterin. In: Wachter H, Curtius HC, Pfleiderer W, eds. Biochemical and clinical aspects of pteridines. Berlin: de Gruyter, 1982:1:117–30.
Hausen A, Wachter H. Pteridines in the assessment of neoplasia. J Clin Chem Clin Biochem 1982;20:593–602.
Huber C, Fuchs D, Niederwieser D, et al. Neopterin, ein neuer biochemischer Marker zur klinischen Erfassung zellularer Immunreaktionen. Klin Wochenschr 1984;62:103–13.
Hausen A, Fuchs D, Reibnegger G, Bichler A, Hetzel H, Wachter H. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases. Cancer Detect Prev 1985;8:121–8.
Lewenhaupt A, Ekman P, Eneroth P, Eriksson A, Nordström L. Serum levels of prostatic acid phosphatase (PAP) tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma. Scand J. Clin Lab Invest 1985;45 (suppl 179):75–80.
Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem 1981;27:1569–74.
McNeil B, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975;293:211–5.
Solberg HE. Discriminant analysis in clinical chemistry. Scand J Clin Lab Invest 1975;35:705–12.
Solberg HE, Skrede S, Blomhoff JP. Diagnosis of liver diseases by laboratory results and discriminant analysis. Scand J Clin Lab Invest 1975;35:713–21.
SPSS Users Guide. New York: McGraw-Hill, 1986.
Dacie JV, Lewis SM. Practical haematology. London: Churchill, 1963:408–10.
Haas R, Gerstner L Radioimmunologische Bestimmung von Neopterin bei Blutspendern. Allerg Immunol 1985;31:179–82.
Mack TM. The evaluation of immunodiagnostic tests. In: Herberman RB, McIntire KR, eds. Immunodiagnosis of cancer. New York: Dekker, 1979:6–20.
Author information
Authors and Affiliations
About this article
Cite this article
Putzki, H., Aschern, F., Henkel, E. et al. Neopterin. Dis Colon Rectum 30, 879–883 (1987). https://doi.org/10.1007/BF02555429
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555429